Camp4 Therapeutics Corp
For the period ended Aug 13, 2026. Filed Aug 13, 2026.
View on SEC.govAbout this filing
A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.
Aug 13, 2026 · Filed Aug 13, 2026
Use the contents to explore the available documents and sections.
Contents
EX-99.1 · Upcoming Virtual Analyst Event
Upcoming Virtual Analyst Event
The Company will host a Virtual Analyst Day on September 28, 2026. The program will provide an overview of the unmet clinical need in SYNGAP-1 related disorders, an overview of the clinical trial design for the Company’s first-in-human Phase 1/2 clinical trial of CMP-002, and an update on the Company’s early discovery pipeline. To register for the Analyst Day please visit the Investor Relations section of the Company's website.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.